Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Strong
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Neurocrine Biosciences, Inc.
Telephone
1.858.617.7600
Address
6027 Edgewood Bend Court, San Diego, CA 92130
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 117.59 - 162.39
Trade Value (12mth)
US$35,120,712.00
1 week
-2.56%
1 month
18.54%
YTD
9.79%
1 year
28.04%
All time high
162.39
EPS 3 yr Growth
198.30%
EBITDA Margin
23.30%
Operating Cashflow
$783m
Free Cash Flow Return
23.30%
ROIC
14.30%
Interest Coverage
0.00
Quick Ratio
3.30
Shares Outstanding (Fully Diluted)
103m
HALO Sector
Healthcare
Next Company Report Date
11-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 18 May 26 | |
| 18 May 26 | |
| 18 May 26 | |
| 06 May 26 | |
| 06 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 2.56 | 3.4 | 4.81 | | | | ||
EPS (Fully Diluted) | $ | | | | | 2.47 | 3.29 | 4.67 | | | | ||
Growth | % | | | | | 58.5 | 33 | 41.5 | | | | ||
PE | X | | | | | 53.3 | 41.5 | 30.4 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 19.6 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
